EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term

Pinar Oner, Seda Yilmaz iD, Serpil Doğan

Journal of Personalized Medicine · 10.03.2023 · 13 (3) · 503

DOI: 10.3390/jpm13030503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 10.03.2023. Verfasst von Pinar Oner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Elazig Fethi Sekin City Hospital, Elazig 23100, Turkey. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we measured the levels of depression and cognition in people recovering from COVID-19. Moreover, we aimed to investigate the relationship between depression and cognition levels by measuring homocysteine concentrations. It included 62 people recovering from COVID-19 (at least 3 months after positive RT-PCR) and 64 people without COVID-19 (control group). At first, the homocysteine levels of participants were measured. Beck Depression Inventory (BDI) and Montreal Cognitive Assessment (MoCA) were performed to collect data. Homocysteine levels of the group recovering from COVID-19 (x− = 19.065 µmol/L) were higher than the control group (x− = 11.313 µmol/L). There was no significant difference between the groups for BDI scores. The MoCA scores of the group recovering from COVID-19 (x− = 20.774) were lower than the control group (x− = 24.297). There was a negative high (r = –0.705, p < 0.001) correlation between homocysteine levels and MoCA scores. Linear regression analysis is shown to be significant, and the MoCA explanatory value of the variables in the model is 58.6% (p < 0.0001). A 1 µmol/L observed increase in homocysteine level constituted a risk for a 0.765-point decrease in MOCA scores. In patients recovering from COVID-19, early interventions to high homocysteine levels may prevent cognitive impairments that may persist in the long term.

Schlagwörter

Stichwörter der Autor:innen

COVID-19cognitiondepressionhomocysteinelong term

Autor:innen und Institutionen

  • Department of Microbiology, Elazig Fethi Sekin City Hospital, Elazig 23100, Turkey.
  • Department of Psychiatry, Elazig Fethi Sekin City Hospital, Elazig 23100, Turkey.
  • Department of Neurology, Elazig Fethi Sekin City Hospital, Elazig 23100, Turkey.

ORCID-Profile: Seda Yilmaz

Zitieren

APA

Oner, P., Yilmaz, S., & Doğan, S. (2023). High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term. Journal of Personalized Medicine, 13(3), 503. https://doi.org/10.3390/jpm13030503

Vancouver

Oner P, Yilmaz S, Doğan S. High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term. Journal of Personalized Medicine. 2023;13(3):503. doi:10.3390/jpm13030503

BibTeX
@article{Oner2023,
  author = {Oner, Pinar and Yilmaz, Seda and Doğan, Serpil},
  title = {High Homocysteine Levels Are Associated with Cognitive Impairment in Patients Who Recovered from COVID-19 in the Long Term},
  journal = {Journal of Personalized Medicine},
  year = {2023},
  volume = {13},
  number = {3},
  pages = {503},
  doi = {10.3390/jpm13030503}
}
Kostenlos starten →